Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

Bullboard Posts

Post by FLYER22on May 12, 2013 1:14am

211 Views

Post# 21370773

Buying Opportunity

I was fortunate to load up on ICO last July on its pullback to high .20s and sold in the .70s in Dec.

I could not believe I had another opportunity to load up again in the low .20s. on Friday. This time that much closer to final data. I will not sell this time until $2.00. This is the best buy on the venture......IMO.

Have talked it up with family and friends over the weekend......Bids will be there!!!!

Bullboard Posts

Debt-free cannabis company set for next stage of growth